Higashikuni Lab
Higashikuni Lab
Home
Projects
Posts
Talks
People
Publications
Contact
Light
Dark
Automatic
RNA Metabolism and Modification
RNA Metabolism and Modification in Cardiovascular disease
Deciphering RNA metabolism and modification in pathogenic mechanism of heart failure for development of novel therapeutic strategies.
Japan Society for Vascular Failure 2026 Hyperuricemia, the Old and New Issue in Cardiovascular Medicine
Our basic research findings and clinical experience provide new insight into therapeutic strategy for hyperuricemia in patients with cardiovascular disease.
Apr 19, 2026 1:25 PM — 2:55 PM
Hiroshima
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
JCS2026 Linking inflammation to heart failure
We will discuss how inflammation causes heart failure.
Mar 22, 2026 10:00 AM — 11:30 AM
Fukuoka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
JCS2026 RNA dynamics and post-translational modifications in cardiac aging
We will discuss RNA dynamics and post-translational modifications in cardiac aging.
Mar 22, 2026 8:00 AM — 9:30 AM
Fukuoka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
JCS2026 Controlling molecular dynamics for the treatment of heart failure
We will discuss synthetic cardiology approach for the treatment of heart failure.
Mar 21, 2026 1:00 PM — 3:00 PM
Fukuoka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Project
The Japanese Pharmacological Society Scientific Meeting 2026 RNA metabolism in heart failure
We will discuss RNA metabolism in heart failure.
Mar 16, 2026 2:00 PM — 3:30 PM
Sendai
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Japanese Society of Gout and Uric and Nucleic Acids Uric acid and Heart failure
We will discuss uric acid in heart disease.
Feb 28, 2026 4:00 PM — 5:30 PM
Fukui
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
BCVR2025 Linking inflammation to metabolic changes in heart disease
We will discuss inflammation and metabolism in heart disease.
Dec 14, 2025 10:00 AM — 12:00 PM
Kyoto
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Compound heterozygous variants of CACNA1H change channel properties and contribute to intractable epilepsy with myoclonic-atonic seizures
The CACNA1H gene, which encodes the T-type calcium channel Cav3.2, is known to confer susceptibility to childhood absence epilepsy …
Ayumi Matsumoto
,
Go Kasuya
,
Suvd Tumurbaatar
,
Takuya Masuda
,
Kei Wakabayashi
,
Masako Kawada
,
Yasutomi Higashikuni, M.D., Ph.D., FESC
,
Kazuhiro Muramatsu
,
Koichi Nakajo
,
Hitoshi Osaka
,
Takayoshi Matsumura
Project
DOI
JCC2025 Cardiac inflammatory signaling in health and disease
We will discuss aging and inflammatory signaling in heart disease.
Sep 21, 2025 8:10 AM — 9:40 AM
Kochi
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
»
Cite
×